Fresenius Medical Care (ETR:FME) Stock Passes Above 200-Day Moving Average – Time to Sell?

Fresenius Medical Care AG (ETR:FMEGet Free Report)’s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of €45.75 ($53.20) and traded as high as €47.23 ($54.92). Fresenius Medical Care shares last traded at €47.17 ($54.85), with a volume of 466,778 shares trading hands.

Fresenius Medical Care Stock Performance

The company has a quick ratio of 0.80, a current ratio of 1.37 and a debt-to-equity ratio of 82.24. The company has a market cap of $13.75 billion, a P/E ratio of 20.86, a P/E/G ratio of 0.42 and a beta of 0.86. The business has a fifty day moving average of €44.14 and a 200 day moving average of €45.75.

Fresenius Medical Care Company Profile

(Get Free Report)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Articles

Receive News & Ratings for Fresenius Medical Care Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care and related companies with MarketBeat.com's FREE daily email newsletter.